| REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Not applicable |
||
(Translation of Registrant’s name into English) |
(Jurisdiction of incorporation or organization) |
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||||||
| ☒ | Emerging growth company | |||||||||
| † | The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting |
| ☒ | International Financial Reporting Standards as issued | Other ☐ | ||||||
| by the International Accounting Standards Board | ☐ |
Page |
||||
ii |
||||
1 |
||||
1 |
||||
3 0 |
||||
3 0 |
||||
3 1 |
||||
3 1 |
||||
Year Ended |
Year Ended |
|||||||
December 31, |
December 31, |
|||||||
2020 |
2019 |
|||||||
| As Reported |
||||||||
| Net loss |
$ |
(30,348 |
) |
$ |
(40,207 |
) | ||
| Preference share accretion |
$ |
— |
$ |
— |
||||
| Net loss attributable to common stockholders – basic and diluted |
$ |
(30,348 |
) |
$ |
(40,207 |
) | ||
| Loss per share attributable to common stockholders - basic and diluted |
$ |
(0.43 |
) |
$ |
(0.59 |
) | ||
| As Restated |
||||||||
| Net loss |
$ |
(30,348 |
) |
$ |
(40,207 |
) | ||
| Preference share accretion |
$ |
(31,870 |
) |
$ |
(28,322 |
) | ||
| Net loss attributable to common stockholders – basic and diluted |
$ |
(62,218 |
) |
$ |
(68,529 |
) | ||
| Loss per share attributable to common stockholders - basic and diluted |
$ |
(0.89 |
) |
$ |
(1.00 |
) | ||
| • | Part I, Item 3, Key Information , D. Risk Factors |
| • | Part II, Item 15, Controls and Procedures |
| • | Part III, Item 18, Financial Statements |
| • | Health epidemics or pandemics, such as COVID-19, can and have adversely affected consumer spending, consumer engagement in sports and entertainment, and reduced the number of sporting live sporting events, all of which can affect our financial results, our business operations, and prospects. |
| • | Our business and operating results and the business and operating results of our customers, suppliers and vendors may be significantly impacted by general economic, political and social conditions, pandemics, wars or terrorist activity, severe weather events and other natural disasters, geopolitical circumstances and events, such as the Russia and Ukraine conflict, and the health of the sports, entertainment and sports betting industries. |
| • | We may not be able to offset higher costs associated with inflation and other general cost increases. |
| • | The international scope of our operations may expose us to increased risk, and our international operations and corporate and financing structure may expose us to potentially adverse tax consequences. |
| • | Fluctuating foreign currency and exchange rates may negatively impact our business, results of operations and financial position. |
| • | We rely on relationships with sports organizations from which we acquire sports data, including, among other things, via arrangements for exclusive rights for such data. Loss of existing relationships, overreliance on certain relationships, or failure to renew or expand existing relationships may cause unanticipated costs or loss of competitive advantage, or require us to modify, limit or discontinue certain offerings, which could materially affect our business, financial condition and results of operations. |
| • | Risks related to the U.K.’s exit from the European Union (“Brexit”) may have a negative effect on global economic conditions, financial markets and our business in years to come. |
| • | We operate in a competitive market and we may lose customers and relationships to both existing and future competitors. |
| • | Fraud, corruption or negligence related to sports events, or by our employees or contracted statisticians collecting data on behalf of the Company, may adversely affect our business, financial condition and results of operations and negatively impact our reputation. |
| • | Our collection, storage and processing of personal data is subject to applicable data protection and privacy laws in various jurisdictions, and any failure to comply with such laws may harm our reputation and business or expose us to fines and other enforcement action. |
| • | We are party to pending litigation and investigations in various jurisdictions and with various plaintiffs and we may be subject to future litigation or investigations in the operation of our business. Protracted litigation costs could negatively affect our operational costs, and an adverse outcome in one or more proceedings could adversely affect our business. |
| • | Failure to protect or enforce our proprietary and intellectual property rights, including our unregistered intellectual property, and the costs involved in such protection and enforcement could harm our business, financial condition, results of operations and prospects. |
| • | We may face claims for intellectual property infringement, which could subject us to monetary damages or limit us in using some of our technologies or providing certain solutions. |
| • | We rely on information technology and other systems and platforms, including our data center and Amazon Web Services and certain other third-party platforms, and failures, errors, defects or disruptions therein could diminish our brand and reputation, subject us to liability, disrupt our business, affect our ability to scale our technical infrastructure and adversely affect our operating results and growth prospects. Our product offerings and other software applications and systems, and certain third-party platforms that we use could contain undetected errors or errors that we fail to identify as material. |
| • | We have a history of losses and may not be able to achieve or sustain profitability in the future. |
| • | Genius may issue additional Genius ordinary shares or other equity securities without your approval, which would dilute your ownership interests and may depress the market price of Genius ordinary shares. |
| • | Because Genius is incorporated under the laws of the States of Guernsey, you may face difficulties in protecting your interests, and your ability to protect your rights through the U.S. Federal courts may be limited. |
| • | It may be difficult to enforce a U.S. judgment against Genius or its directors and officers outside the United States, or to assert U.S. securities law claims outside of the United States. |
| • | As a company incorporated in the States of Guernsey, we are permitted to adopt certain home country practices in relation to corporate governance matters that differ, and in some cases significantly differ, from NYSE corporate governance listing standards; these practices may, and in some cases does afford less protection to shareholders than they would enjoy if we complied fully with NYSE corporate governance listing standards. |
| • | We have identified a material weakness in our internal control over financial reporting. This material weakness could affect our ability to report our results of operations and financial condition accurately and in a timely manner. |
| • | the ability to profitably manage acquired businesses or successfully integrate the acquired businesses’ operations, culture, personnel, financial reporting, accounting and internal controls, technologies and products into our business; |
| • | increased indebtedness and the expense of integrating acquired businesses, including significant administrative, operational, economic, geographic or cultural challenges in managing and integrating the expanded or combined operations; |
| • | entry into jurisdictions or acquisition of products or technologies with which we have limited or no prior experience, and the potential of increased competition with new or existing competitors as a result of such acquisitions; |
| • | exposure to compliance, intellectual property or other issues, not uncovered by a limited due diligence review of the target or otherwise; |
| • | diversion of management’s attention and the over-extension of our operating infrastructure and our management systems, information technology systems, and internal controls and procedures, which may be inadequate to support growth; |
| • | bringing new businesses into compliance with various laws and regulations, including but not limited to Sarbanes Oxley Section 404, and implementing adequate financial, risk and compliance controls to ensure appropriate financial reporting. |
| • | failure to fully integrate new business into our operations and difficulty in utilizing personnel and technology effectively. |
| • | the ability to fund our capital needs and any cash flow shortages that may occur if anticipated revenue is not realized or is delayed, whether by general economic or market conditions, or unforeseen internal difficulties; and |
| • | the ability to retain or hire qualified personnel required for expanded operations. |
| • | political instability; |
| • | international hostilities, military actions, terrorist or cyber-terrorist activities, natural disasters, pandemics, and infrastructure disruptions; |
| • | differing economic cycles and adverse economic conditions; |
| • | unexpected changes in regulatory environments and government interference in the economy, including gambling, data privacy and advertising laws and regulations; |
| • | changes to economic and anti-money laundering sanctions, laws and regulations; |
| • | varying tax regimes, including with respect to the imposition of withholding taxes on remittances and other payments by our partnerships or subsidiaries; |
| • | inflation fluctuations in various regions where our revenues are contingent upon consumer spending. |
| • | differing labor regulations; |
| • | foreign exchange controls and restrictions on repatriation of funds; |
| • | fluctuations in currency exchange rates; |
| • | increased costs for corporate, administrative and personnel costs to support operations in various jurisdictions; |
| • | inability to collect payments or seek recourse under or comply with ambiguous or vague commercial or other laws; |
| • | insufficient protection against product piracy and rights infringement and differing protections for intellectual property rights; |
| • | varying attitudes towards sports data providers and betting by foreign governments; |
| • | difficulties in attracting and retaining qualified management and employees, or rationalizing our workforce; |
| • | differing business practices, which may require us to enter into agreements that include non-standard terms; and |
| • | difficulties in penetrating new markets due to entrenched competitors, lack of recognition of our brands or lack of local acceptance of our products, lack of local expertise and services. |
| • | actual or anticipated fluctuations in Genius’s quarterly financial results or the quarterly financial results of companies perceived to be similar to Genius; |
| • | changes in the market’s expectations about Genius’s operating results; |
| • | success of competitors; |
| • | Genius’s operating results failing to meet the expectation of securities analysts or investors in a particular period; |
| • | changes in financial estimates and recommendations by securities analysts concerning Genius or the industries in which Genius operates in general; |
| • | operating and share price performance of other companies that investors deem comparable to Genius; |
| • | Genius’s ability to market new and enhanced products on a timely basis; |
| • | changes in laws and regulations affecting Genius’s business; |
| • | concerns over customers business or the wider consumer market for sportsbooks; |
| • | commencement of, or involvement in, litigation involving Genius; |
| • | changes in Genius’s capital structure, such as future issuances of securities (including, but not limited to, pursuant to stock option plans and other equity compensation arrangements available to officers, directors or employees, or other equity issuance transactions for which Genius, as a foreign private issuer, is not required by NYSE corporate governance listing standards to seek shareholder approval) or the incurrence of additional debt; |
| • | changes in significant shareholding |
| • | the volume of Genius ordinary shares available for public sale; |
| • | any major change in Genius’s management or Board of Directors; |
| • | social, environmental or governance factors relating to our relationship to sportsbooks or otherwise; |
| • | sales of substantial amounts of Genius ordinary shares by Genius’s directors, executive officers or significant shareholders or the perception that such sales could occur; and |
| • | general economic and political conditions such as recessions, interest rates, fuel prices, inflation, international currency fluctuations and acts of war or terrorism. |
| • | Genius’s existing shareholders’ proportionate ownership interest in Genius may decrease; |
| • | the amount of cash available per share, including for payment of dividends in the future, may decrease; |
| • | the relative voting strength of each previously outstanding Genius ordinary share may be diminished; and |
| • | the market price of Genius ordinary shares may decline. |
| • | acquires an interest in Genius shares that, when taken together with shares in which persons acting in concert with such person are interested, carry 30% or more of the voting rights of Genius; or |
| • | together with persons acting in concert with such person, is interested in shares that in the aggregate carry not less than 30% of Genius’ voting rights but does not hold shares carrying more than 50% of such voting rights, and such person (or any person acting in concert with such person) acquires additional interests in Genius shares that increase the percentage of shares carrying voting rights in which that person is interested, |
| * | Filed herewith. |
| ** | Furnished herewith. |
GENIUS SPORTS LIMITED | ||||||
| November 10, 2022 | ||||||
| By: | /s/ Mark Locke | |||||
| Name: | Mark Locke | |||||
| Title: | Chief Executive Officer and Director | |||||
December 31 |
December 31 |
|||||||
2021 |
2020 |
|||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Accounts receivable, net |
||||||||
Contract assets |
||||||||
Prepaid expenses |
||||||||
Other current assets |
||||||||
Total current assets |
||||||||
Property and equipment, net |
||||||||
Intangible assets, net |
||||||||
Goodwill |
||||||||
Deferred tax asset |
||||||||
Other assets |
||||||||
Total assets |
$ |
$ |
||||||
LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ EQUITY (DEFICIT) |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued expenses |
||||||||
Deferred revenue |
||||||||
Current debt |
||||||||
Derivative warrant liabilities |
||||||||
Other current liabilities |
||||||||
Total current liabilities |
||||||||
Long-term debt – less current portion |
||||||||
Deferred tax liability |
||||||||
Other liabilities |
||||||||
Total liabilities |
||||||||
Temporary equity: |
||||||||
Preference shares, $ |
||||||||
Total temporary equity |
||||||||
Shareholders’ equity (deficit) |
||||||||
Common stock, $ ited shares authorized, |
||||||||
B Shares, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Accumulated other comprehensive income (loss) |
( |
) | ||||||
Total shareholders’ equity (deficit) |
( |
) | ||||||
Total liabilities, temporary equity and shareholders’ equity (deficit) |
$ |
$ |
||||||
(As Revised) |
(As Restated) |
(As Restated) |
||||||||||
Year Ended |
Year Ended |
Year Ended |
||||||||||
December 31, |
December 31, |
December 31, |
||||||||||
2021 |
2020 |
2019 |
||||||||||
| Revenue |
$ | $ | $ | |||||||||
| Cost of revenue |
||||||||||||
| |
|
|
|
|
|
|||||||
| Gross (loss) profit |
( |
) | ||||||||||
| |
|
|
|
|
|
|||||||
| Operating expenses: |
||||||||||||
| Sales and marketing |
||||||||||||
| Research and development |
||||||||||||
| General and administrative |
||||||||||||
| Transaction expenses |
||||||||||||
| |
|
|
|
|
|
|||||||
| Total operating expense |
||||||||||||
| |
|
|
|
|
|
|||||||
| Loss from operations |
( |
) | ( |
) | ( |
) | ||||||
| |
|
|
|
|
|
|||||||
| Interest expense, net |
( |
) | ( |
) | ( |
) | ||||||
| Loss on disposal of assets |
( |
) | ( |
) | ( |
) | ||||||
| Gain (loss) on fair value remeasurement of contingent consideration |
( |
) | ||||||||||
| Change in fair value of derivative warrant liabilities |
( |
) | ||||||||||
| Gain (loss) on foreign currency |
( |
) | ||||||||||
| |
|
|
|
|
|
|||||||
| Total other income (expenses) |
( |
) | ( |
) | ( |
) | ||||||
| |
|
|
|
|
|
|||||||
| Loss before income taxes |
( |
) | ( |
) | ( |
) | ||||||
| |
|
|
|
|
|
|||||||
| Income tax benefit (expense) |
( |
) | ||||||||||
| |
|
|
|
|
|
|||||||
| Net loss |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
| |
|
|
|
|
|
|||||||
| Preference share accretion |
( |
) | ( |
) | ( |
) | ||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss attributable to common stockholders |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
| |
|
|
|
|
|
|||||||
| Loss per share attributable to common stockholders: |
||||||||||||
| Basic and diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| Weighted average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
| Basic and diluted |
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
Year Ended |
Year Ended |
||||||||||
December 31, |
December 31, |
December 31, |
||||||||||
2021 |
2020 |
2019 |
||||||||||
| Net loss |
$ | ( |
$ | ( |
$ | ( |
||||||
| Other comprehensive loss: |
|
|||||||||||
| Foreign currency translation adjustments |
( |
) | ||||||||||
| |
|
|
|
|
|
|||||||
| Comprehensive loss |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
| |
|
|
|
|
|
|||||||
Temporary Equity |
Permanent Equity |
|||||||||||||||||||||||||||||||||||||||
Preference Shares |
Amounts |
Common Stock |
Amounts |
B Shares |
Amounts |
Additional Paid in Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Income (Loss) |
Total Shareholders’ Equity (Deficit) |
|||||||||||||||||||||||||||||||
| Balance at January 1, 2019 |
$ |
$ |
— |
$ |
— |
$ |
$ |
( |
) |
$ |
( |
$ |
( |
) | ||||||||||||||||||||||||||
| Retroactive application of reverse capitalization |
— | — | — | — | ( |
) | — | — | — | |||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Balance at January 1, 2019, effect of (see Note 2 – reverse capitalization Reverse ) |
$ |
$ |
— |
$ |
— |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Net loss |
— | — | — | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||
| Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
| Issuance of common shares |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
| Issuance of preference shares |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
| Preferred share accretion |
— | — | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Balance at December 31, 2019 |
$ |
$ |
— |
$ |
— |
$ |
$ |
( |
$ |
$ |
( |
) | ||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Net loss |
— | — | — | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||
| Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
| Preferred share accretion |
— | — | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Balance at December 31, 2020 |
$ |
$ |
— |
$ |
— |
$ |
$ |
( |
) |
$ |
$ |
( |
) | |||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Net loss |
— | — | — | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||
| Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||||||||
| Preferred share accretion |
— | — | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||||||
| Merger recapitalization |
( |
) | ( |
) | — | — | — | — | ||||||||||||||||||||||||||||||||
| Merger and PIPE financing, net of equity issuance costs of $ |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
| Issuance of common stock in connection with additional equity offering, net of equity issuance costs of $ |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
| Issuance of common stock in connection with business combinations |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
| Stock-based compensation |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
| Vesting of restricted shares |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
| Issuance of B shares |
— | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
| Issuance of common stock in connection with additional equity offering, net of equity issuance costs of $ |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
| Issuance of common stock in connection with warrant redemptions |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Balance at December 31, 2021 |
— |
$ |
— |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
$ |
||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Year Ended December 31, |
Year Ended December 31, |
Year Ended December 31, |
||||||||||
2021 |
2020 |
2019 |
||||||||||
Cash Flows from operating activities: |
||||||||||||
Net loss |
$( |
$( |
$( |
|||||||||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
||||||||||||
Depreciation and amortization |
||||||||||||
Loss on disposal of assets |
||||||||||||
(Gain) loss on fair value remeasurement of contingent consideration |
( |
) | — | |||||||||
Stock-based compensation |
— | — | ||||||||||
Change in fair value of derivative warrant liabilities |
— | — | ||||||||||
Non-cash interest expense (income), net |
||||||||||||
Amortization of contract cost |
||||||||||||
Deferred income taxes |
( |
) | ( |
) | ||||||||
Loss on foreign currency remeasurement |
||||||||||||
Changes in assets and liabilities |
||||||||||||
Effect of business combinations |
( |
) | — | — | ||||||||
Accounts receivable, net |
( |
) | ( |
) | ( |
) | ||||||
Contract asset |
( |
) | ( |
) | ( |
) | ||||||
Prepaid expenses |
( |
) | ( |
) | ( |
) | ||||||
Other current assets |
( |
) | ( |
) | ||||||||
Other assets |
( |
) | ( |
) | ||||||||
Accounts payable |
( |
) | ||||||||||
Accrued expenses |
||||||||||||
Deferred revenue |
||||||||||||
Other current liabilities |
||||||||||||
Other liabilities |
( |
) | ||||||||||
Net cash provided by (used in) operating activities |
( |
) |
||||||||||
Cash flows from investing activities: |
||||||||||||
Purchases of property and equipment |
( |
) | ( |
) | ( |
) | ||||||
Capitalization of internally developed software costs |
( |
) | ( |
) | ( |
) | ||||||
Repayment of executive loan notes |
— | — | ||||||||||
Purchases of intangible assets |
( |
) | ( |
) | ( |
) | ||||||
Acquisition of business, net of cash acquired |
( |
) | ( |
) | ( |
) | ||||||
Proceeds from disposal of assets |
||||||||||||
Net cash used in investing activities |
( |
) |
( |
) |
( |
) | ||||||
Cash flows from financing activities: |
||||||||||||
Proceeds from merger with dMY Technology Group, Inc. II |
— | — | ||||||||||
Proceeds from issuance of common shares |
— | — | ||||||||||
Proceeds from issuance of preference shares |
— | — | ||||||||||
Payment of contingent consideration |
— | — | ( |
) | ||||||||
dMY Technology Group, Inc. II transaction costs |
( |
) | — | — | ||||||||
Capitalization of Genius equity issuance costs |
( |
) | — | — | ||||||||
PIPE financing, net of equity issuance costs |
— | — | ||||||||||
Issuance of common stock in connection with additional equity offering, net of equity issuance costs |
— | — | ||||||||||
Issuance of B shares |
— | — | ||||||||||
Preference shares payout and Incentive Securities Catch-Up Payment |
( |
) | — | — | ||||||||
Repayment of loans and mortgage |
( |
) | ( |
) | ( |
) | ||||||
Proceeds from borrowings |
— | |||||||||||
Proceeds from exercise of Public Warrants |
— | — | ||||||||||
Proceeds from shareholder deposits |
— | |||||||||||
Net cash provided by financing activities |
||||||||||||
Effect of exchange rate changes on cash |
( |
) | ( |
) | ( |
) | ||||||
Net increase (decrease) in cash |
( |
) | ||||||||||
Cash, beginning of period |
||||||||||||
Cash, end of period |
$ | $ | $ | |||||||||
Supplemental disclosure of cash activities: |
||||||||||||
Cash paid during the period for interest |
$ | $ | $ | |||||||||
Cash paid during the period for income taxes |
$ | $ | $ | |||||||||
Supplemental disclosure of noncash investing and financing activities: |
||||||||||||
Preferred share accretion |
$ | $ | $ | |||||||||
Deferred offering costs included in other current assets and accrued expenses |
$ | — | $ | $ | — | |||||||
Contingent consideration for acquisition of business included in other liabilities |
$ | — | $ | — | $ | |||||||
Conversion of preference shares to common stock |
$ | $ | — | $ | — | |||||||
Warrants acquired as part of merger with dMY Technology Group, Inc. II |
$ | ( |
) | $ | — | $ | — | |||||
Exercise of Private Placement Warrants |
$ | $ | — | $ | — | |||||||
Note |
1. Description of Business and Summary of Significant Accounting Policies |
Year Ended |
Year Ended |
|||||||
December 31, |
December 31, |
|||||||
2020 |
2019 |
|||||||
| As Reported |
||||||||
| Preference share accretion |
$ |
$ |
||||||
| Net loss attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) | ||
| Loss per share attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) | ||
| Adjustment |
||||||||
| Preference share accretion |
$ |
( |
) |
$ |
( |
) | ||
| Net loss attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) | ||
| Loss per share attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) | ||
| As Restated |
||||||||
| Preference share accretion |
$ |
( |
) |
$ |
( |
) | ||
| Net loss attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) | ||
| Loss per share attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) | ||
Three Months Ended |
Three Months Ended |
Nine Months Ended |
Three Months Ended |
Six Months Ended |
Three Months Ended |
Nine Months Ended |
||||||||||||||||||||||
March 31, |
September 30, |
September 30, |
June 30, |
June 30, |
March 31, |
September 30, |
||||||||||||||||||||||
2021 |
2020 |
2020 |
2020 |
2020 |
2020 |
2019 |
||||||||||||||||||||||
| As Reported |
||||||||||||||||||||||||||||
| Preference share accretion |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||
| Net loss attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||||
| Loss per share attributable to common stockholders - basic and diluted |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||||
| Adjustment |
||||||||||||||||||||||||||||
| Preference share accretion |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||||
| Net loss attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||||
| Loss per share attributable to common stockholders - basic and diluted |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||||
| As Restated |
||||||||||||||||||||||||||||
| Preference share accretion |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||||
| Net loss attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||||
| Loss per share attributable to common stockholders - basic and diluted |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||||
Year Ended |
||||
December 31, |
||||
2021 |
||||
| As Reported |
||||
| Preference share accretion |
$ |
|||
| Net loss attributable to common stockholders – basic and diluted |
$ |
( |
) | |
| Loss per share attributable to common stockholders - basic and diluted |
$ |
( |
) | |
| Adjustment |
||||
| Preference share accretion |
$ |
( |
) | |
| Net loss attributable to common stockholders – basic and diluted |
$ |
( |
) | |
| Loss per share attributable to common stockholders - basic and diluted |
$ |
( |
) | |
| As Revised |
||||
| Preference share accretion |
$ |
( |
) | |
| Net loss attributable to common stockholders – basic and diluted |
$ |
( |
) | |
| Loss per share attributable to common stockholders - basic and diluted |
$ |
( |
) | |
Nine Months Ended |
Three Months Ended |
Six Months Ended |
||||||||||
September 30, |
June 30, |
June 30, |
||||||||||
2021 |
2021 |
2021 |
||||||||||
| As Reported |
||||||||||||
| Preference share accretion |
$ |
$ |
$ |
|||||||||
| Net loss attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
| Loss per share attributable to common stockholders - basic and diluted |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
| Adjustment |
||||||||||||
| Preference share accretion |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
| Net loss attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
| Loss per share attributable to common stockholders - basic and diluted |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
| As Revised |
||||||||||||
| Preference share accretion |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
| Net loss attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
| Loss per share attributable to common stockholders - basic and diluted |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
Estimated Useful Lives | ||
(years) | ||
Buildings |
||
IT equipment |
||
Furniture and fixtures |
||
Other equipment |
| • | Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. |
| • | Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. |
| • | Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date. |
| • | Identify the contract, or contracts, with the customer; |
| • | Identify the performance obligations in the contract; |
| • | Determine the transaction price; |
| • | Allocate the transaction price to performance obligations in the contract; and |
| • | Recognize revenue when, or as, the Company satisfies performance obligations by transferring the promised good or services. |
dMY Class A common stock outstanding prior to the Merger |
||||
Less: redemption of dMY shares |
||||
Genius ordinary shares issued to dMY Class A common stockholders |
||||
Genius ordinary shares issued to dMY Class B common stockholders |
||||
Genius ordinary shares issued to PIPE Investors |
||||
Total Genius ordinary shares issued in connection with the Merger and PIPE Investment |
||||
Genius ordinary shares converted from legacy Maven Topco shares (1) |
||||
Total Genius ordinary shares issued immediately after the Merger |
(1) |
Includes – Stock-based Compensation fo r further details. |
Consideration Transferred |
||||
Cash for outstanding Second Spectrum capital stock (1) |
$ | |||
Fair value of Genius Sports Limited common stock issued for outstanding Second Spectrum capital stock (2) |
||||
Cash for vested outstanding Second Spectrum equity awards (3) |
||||
Total consideration transferred |
$ |
|||
(1) |
Includes cash consideration paid to former Second Spectrum shareholders totaling $ |
(2) |
Represents the issuance of , 2021 closing price of $ – Fair Value Measurements for details of additional shares issued in early 2022. |
(3) |
Includes $ , 2021 associated with the pre-acquisition services provided by former Second Spectrum shareholders. |
Fair value of net assets acquired |
||||
Cash and cash equivalents |
$ | |||
Accounts receivables, net |
||||
Prepaid expenses |
||||
Other current assets |
||||
Property and equipment, net |
||||
Intangible assets, net |
||||
Other assets |
||||
Goodwill (1) |
||||
Total assets acquired |
$ |
|||
Accounts payable |
||||
Accrued expenses |
||||
Deferred revenue |
||||
Other current liabilities |
||||
Deferred tax liability |
||||
Total liabilities assumed |
$ |
|||
Total consideration transferred |
$ |
|||
(1) |
Reflects a working capital adjustment of $ |
Useful Lives |
As of June 15, 2021 |
|||||
(years) |
(in thousands) |
|||||
| Technology |
$ | |||||
| Marketing products (1) |
||||||
| |
|
|||||
| Total intangible assets acquired subject to amortization |
$ |
|||||
| |
|
|||||
(1) |
Includes customer relationships of $ |
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
| Pro forma revenue |
$ | $ | ||||||
| Pro forma net loss |
( |
) | ( |
) | ||||
(1) |
Transaction costs of approximately $ |
(2) |
Payment of approximately $ |
Year Ended December 31, |
Year Ended December 31, |
Year Ended December 31, |
||||||||||
2021 |
2020 |
2019 |
||||||||||
| Revenue by Product Group |
||||||||||||
| Betting Technology, Content and Services |
$ | $ | $ | |||||||||
| Media Technology, Content and Services |
||||||||||||
| Sports Technology and Services |
||||||||||||
| |
|
|
|
|
|
|||||||
| Total |
$ |
$ |
$ |
|||||||||
| |
|
|
|
|
|
|||||||
Year Ended December 31, |
Year Ended December 31, |
Year Ended December 31, |
||||||||||
2021 |
2020 |
2019 |
||||||||||
| Revenue by geographical market: |
||||||||||||
| Europe |
$ | $ | $ | |||||||||
| Americas |
||||||||||||
| Rest of the world |
||||||||||||
| |
|
|
|
|
|
|||||||
| Total |
$ |
$ |
$ |
|||||||||
| |
|
|
|
|
|
|||||||
As of December 31, 2021 |
As of December 31, 2020 |
|||||||
| Balance, beginning of period |
$ | $ | ||||||
| Increase (decrease) in provision |
||||||||
| Write-offs, net of recoveries |
( |
) | ( |
) | ||||
| Foreign currency translation adjustments |
( |
) | ||||||
| |
|
|
|
|||||
| Balance, end of period |
$ |
$ |
||||||
| |
|
|
|
|||||
As of December 31, |
As of December 31, |
|||||||
2021 |
2020 |
|||||||
| Buildings |
$ | $ | ||||||
| IT Equipment |
||||||||
| Furniture and fixtures |
||||||||
| Other equipment |
||||||||
| |
|
|
|
|||||
| Total property and equipment |
$ | $ | ||||||
| |
|
|
|
|||||
| Less: accumulated depreciation |
||||||||
| |
|
|
|
|||||
| Property and equipment, net |
$ |
$ |
||||||
| |
|
|
|
|||||
| Balance as of December 31, 2019 |
$ | |||
| Goodwill acquired |
||||
| Effect of currency translation remeasurement |
||||
| |
|
|||
| Balance as of December 31, 2020 |
$ | |||
| Goodwill acquired (1) |
||||
| Effect of currency translation remeasurement |
( |
) | ||
| |
|
|||
| Balance as of December 31, 2021 |
$ |
|||
| |
|
(1) |
Includes a working capital adjustment of $ |
Weighted Average Remaining Useful Lives |
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
|||||||||||
(years) |
||||||||||||||
| Data rights |
$ | $ | $ | |||||||||||
| Marketing products |
||||||||||||||
| Technology |
||||||||||||||
| Capitalized software |
||||||||||||||
| |
|
|
|
|
|
|||||||||
| Total intangible assets |
$ |
$ |
$ |
|||||||||||
| |
|
|
|
|
|
|||||||||
Weighted Average Remaining Useful Lives |
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
|||||||||||
(years) |
(in thousands) |
|||||||||||||
| Data rights |
$ | $ | $ | |||||||||||
| Marketing products |
||||||||||||||
| Technology |
||||||||||||||
| Capitalized software |
||||||||||||||
| |
|
|
|
|
|
|||||||||
| Total intangible assets |
$ |
$ |
$ |
|||||||||||
| |
|
|
|
|
|
|||||||||
Fiscal Years |
(in thousands) |
|||
2022 |
$ | |||
2023 |
||||
2024 |
||||
2025 |
||||
2026 |
||||
Thereafter |
||||
Total |
$ |
|||
Note |
9. Other Assets |
December 31, 2021 |
December 31, 2020 |
|||||||
Other current assets: |
||||||||
Non-trade receivables |
$ | $ | ||||||
Deferred offering costs |
— | |||||||
Executive note receivable |
— | |||||||
Inventory |
||||||||
Total other current assets |
$ |
$ |
||||||
Other assets: |
||||||||
Security deposit |
$ | $ | ||||||
Corporate tax receivable |
||||||||
Sales tax receivable |
||||||||
Contract costs |
||||||||
Total other assets |
$ |
$ |
||||||
Note |
10. Debt |
Instrument |
Date of Issuance |
Maturity Date |
Effective interest rate |
December 31, 2021 |
December 31, 2020 |
|||||||||||
Investor Loan Notes |
September 2018 to December 2019 |
$ | — | $ | ||||||||||||
Genius Sports Italy Srl Mortgage |
December 2010 |
|||||||||||||||
Related party loan |
December 2020 |
— | ||||||||||||||
| $ | $ | |||||||||||||||
Less current portion of debt |
( |
) | ( |
) | ||||||||||||
Non-current portion of debt |
$ |
$ |
||||||||||||||
Fiscal Period: |
(in thousands) |
|||
2022 |
$ | |||
2023 |
||||
2024 |
||||
2025 |
||||
2026 |
||||
Thereafter |
||||
Total payment outstanding |
$ |
|||
December 31, 2021 |
December 31, 2020 |
|||||||
| Other current liabilities: |
||||||||
| Other payables |
$ | $ | ||||||
| Deferred consideration |
— | |||||||
| Contingent consideration |
||||||||
| |
|
|
|
|||||
| Total other current liabilities |
$ |
$ |
||||||
| |
|
|
|
|||||
| Other liabilities: |
||||||||
| Deferred consideration |
$ | $ | — | |||||
| Contingent consideration |
||||||||
| Incentive securities |
— | |||||||
| |
|
|
|
|||||
| Total other liabilities |
$ |
$ |
||||||
| |
|
|
|
|||||
Year ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
(As Revised) |
(As Restated) |
(As Restated) |
||||||||||
| Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| Preference share accretion |
( |
) | ( |
) | ( |
) | ||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss attributable to common stockholders – basic and diluted |
( |
) | ( |
) | ( |
) | ||||||
| Basic and diluted weighted average common stock outstanding |
||||||||||||
| |
|
|
|
|
|
|||||||
| Loss per share attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
| |
|
|
|
|
|
|||||||
Year ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
| Stock options to purchase common stock |
— | — | ||||||||||
| Unvested restricted shares |
— | — | ||||||||||
| Public Warrants to purchase common stock |
— | — | ||||||||||
| Warrants issued to NFL to purchase common stock |
— | — | ||||||||||
| Preference shares |
— | |||||||||||
| Incentive Securities |
— | |||||||||||
| |
|
|
|
|
|
|||||||
| Total |
||||||||||||
| |
|
|
|
|
|
|||||||
| Common share and equivalents price - marketable (1) |
$ | |
||
| Discount for lack of marketability (“DLOM”) (2) |
% | |||
| *Term (3) |
years | |||
| *Volatility (4) |
% | |||
| *Risk-free rate (5) |
% |
(1) |
Represents the publicly traded common stock price of dMY as of the modification date on October 27, 2020 |
(2) |
Represents the discount for lack of marketability of the historical Incentive Securities as of the modification date on October 27, 2020 (subsequently converted to restricted shares upon Closing), calculated using the Finnerty Method |
(3) |
Represents the sum of the expected term from the modification date to Closing (6 months) and the vesting period of 4 years for Performance-Vesting Restricted Shares |
(4) |
Calculated based on comparable companies’ historical volatilities over a matching term of |
(5) |
Based on the U.S. Constant Maturity Treasury yield curve as of the modification date over a matching term of |
* |
Only used to estimate the modification date fair value of historical Class D Incentive Securities (subsequently converted to Performance-Vesting Restricted Shares) under Monte Carlo simulations |
Number of Shares |
Weighted Average Grant Date Fair Value per Share |
|||||||
| Unvested restricted shares as of December 31, 2020 |
— | |||||||
| Granted |
$ | |
||||||
| Forfeited |
( |
) | $ | |||||
| Vested |
( |
) | $ | |||||
| |
|
|||||||
| Unvested restricted shares as of December 31, 2021 |
$ | |||||||
| |
|
|||||||
| Time to maturity (1) |
||||
| Common stock price (2) |
$ | |
||
| Volatility (3) |
% | |||
| Risk-free rate (4) |
% | |||
| Strike price (1) |
$ | |||
| Dividend yield (5) |
% |
(1) |
Based on contractual terms |
(2) |
Represents the publicly traded common stock price as of the Grant Date |
(3) |
Calculated based on comparable companies’ historical volatilities over a matching term of |
(4) |
Based on the U.S. Constant Maturity Treasury yield curve as of the valuation date over a matching term over |
(5) |
Assumes a dividend yield of zero as the Company has no plans to declare dividends in the foreseeable future |
Number of Options |
Weighted Average Exercise Price |
Weighted Average Remaining Contractual Life |
Aggregate Intrinsic Value |
|||||||||||||
(in years) |
(in thousands) |
|||||||||||||||
| Outstanding as of December 31, 2020 |
— | |||||||||||||||
| Granted |
$ | |||||||||||||||
| Forfeited |
( |
) | $ | |||||||||||||
| |
|
|||||||||||||||
| Outstanding as of December 31, 2021 |
$ | $ | ||||||||||||||
| Exercisable as of December 31, 2021 |
||||||||||||||||
| |
|
|||||||||||||||
| Unvested as of December 31, 2021 |
||||||||||||||||
Number of Warrants |
Weighted Averaged Exercise Price |
|||||||
| Outstanding as of December 31, 2020 |
||||||||
| Issued |
$ | |||||||
| |
|
|||||||
| Outstanding as of December 31, 2021 |
||||||||
| |
|
|||||||
Awards Outstanding |
Weighted Averaged Exercise Price |
Aggregate Intrinsic Value |
||||||||||
(in thousands) |
||||||||||||
| Unvested awards December 31, 2020 |
$ | $ | ||||||||||
| Converted |
( |
) | $ | |||||||||
| |
|
|||||||||||
| Outstanding as of December 31, 2021 |
$ | — | ||||||||||
| |
|
|||||||||||
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
| Cost of revenue |
$ | $ | $ | |||||||||
| Sales and marketing |
||||||||||||
| Research and development |
||||||||||||
| General and administrative |
||||||||||||
| |
|
|
|
|
|
|||||||
| Total |
$ |
$ |
$ |
|||||||||
| |
|
|
|
|
|
|||||||
Description |
Level 1 |
Level 2 |
Level 3 |
Total |
||||||||||||
| Liabilities: |
||||||||||||||||
| Public Warrants |
$ | $ | — | $ | — | $ | ||||||||||
| Contingent Consideration |
— | |||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Total liabilities |
$ |
$ |
$ |
$ |
||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
As of September 15, 2021 |
As of April 20, 2021 |
|||||||
| Exercise price |
$ | $ | ||||||
| Stock price |
$ | $ | ||||||
| Volatility |
% | % | ||||||
| Term |
years | years | ||||||
| Risk-free rate |
% | % | ||||||
| Dividend yield |
% | % | ||||||
Public Warrants |
Private Placement Warrants |
Total |
||||||||||
| Initial measurement at April 20, 2021 |
$ | $ | $ | |||||||||
| Change in fair value |
( |
) | ||||||||||
| Exercise of warrants |
( |
) | ( |
) | ( |
) | ||||||
| Foreign currency translation adjustments |
( |
) | ( |
) | ( |
) | ||||||
| |
|
|
|
|
|
|||||||
| Derivative warrant liabilities at December 31, 2021 |
$ |
$ |
$ |
|||||||||
| |
|
|
|
|
|
|||||||
2021 |
2020 |
|||||||
| Beginning balance – January 1 |
$ | $ | ||||||
| Additions (1) |
||||||||
| (Gain) loss on fair value remeasurement of contingent consideration (2) |
( |
) | ||||||
| Foreign currency translation adjustments |
||||||||
| |
|
|
|
|||||
| Ending balance – December 31 |
$ |
$ |
||||||
| |
|
|
|
|||||
(1) |
Additions during the year ended December 31, 2021 represent contingent consideration liabilities arising from the Spirable acquisition (refer to Note 3 – Business Combinations ) in the third quarter of 2021. |
(2) |
(Gain) loss on fair value remeasurement of contingent consideration mainly consist of an increase in the obligation to the former management shareholders of Second Spectrum as the lock-up period expired on December 31, 2021. Pursuant to the terms and conditions of the business combination agreement with Second Spectrum, the Company will issue an additional |
Year Ended December 31, 2021 |
Year Ended December 31, 2020 |
Year Ended December 31, 2019 |
||||||||||
U.K. |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Foreign |
( |
) | ( |
) | ( |
) | ||||||
Loss before income taxes |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
Year Ended December 31, |
Year Ended December 31, |
Year Ended December 31, |
||||||||||
2021 |
2020 |
2019 |
||||||||||
Current: |
||||||||||||
U.K. |
$ | $ | $ | |||||||||
Foreign |
||||||||||||
Current tax expense |
||||||||||||
Deferred: |
||||||||||||
U.K. |
( |
) | ( |
) | ||||||||
Foreign |
( |
) | ||||||||||
Deferred tax expense (benefit) |
( |
) | ( |
) | ||||||||
Total |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Year Ended December 31, |
Year Ended December 31, |
Year Ended December 31, |
||||||||||
2021 |
2020 |
2019 |
||||||||||
U.K. provision at statutory rate |
% | % | % | |||||||||
Expenses not deductible for tax purposes |
( |
) | ( |
) | ||||||||
Return to provision |
( |
) | ||||||||||
Non-deductible interest expense |
( |
) | ||||||||||
Income not taxable |
||||||||||||
Stock based compensation |
( |
) | ||||||||||
Chargeable gains/(losses) |
||||||||||||
Remeasurement of warrant liability |
||||||||||||
Transaction cost adjustment |
( |
) | ||||||||||
Tax rate change |
( |
) | ||||||||||
Foreign rate difference |
( |
) | ||||||||||
Change in valuation allowance |
( |
) | ( |
) | ( |
) | ||||||
Effective tax rate |
% |
( |
)% |
% | ||||||||
Year Ended December 31, |
Year Ended December 31, |
|||||||
2021 |
2020 |
|||||||
Deferred tax assets: |
||||||||
Net operating loss carry forward |
$ | $ | ||||||
Property and equipment |
( |
) | ||||||
Other |
||||||||
Deferred tax assets before valuation allowance |
||||||||
Valuation allowance |
( |
) | ( |
) | ||||
Deferred tax assets, net of valuation allowance |
||||||||
Deferred tax liabilities: |
||||||||
Outside basis difference |
||||||||
Intangible assets |
||||||||
Deferred tax liabilities |
||||||||
Net deferred tax assets (liabilities) |
$ |
( |
) |
$ |
( |
) | ||
Years Ended December 31 |
(in thousands) |
|||
2022 |
$ | |||
2023 |
||||
2024 |
||||
2025 |
||||
2026 |
||||
Thereafter |
||||
Total |
$ |
|||
Years Ended December 31 |
(in thousands) |
|||
2022 |
$ | |
||
2023 |
||||
2024 |
||||
2025 |
||||
2026 |
||||
Thereafter |
||||
Total |
$ |
|||